干细胞之家 - 中国干细胞行业门户第一站

 

 

搜索
朗日生物

免疫细胞治疗专区

欢迎关注干细胞微信公众号

  
查看: 10548|回复: 1
go

求文献。。。关于fibronectin,有点多 [复制链接]

Rank: 2

积分
298 
威望
298  
包包
188  

优秀会员

楼主
发表于 2014-3-26 11:51 |只看该作者 |倒序浏览 |打印
1.Fibronectin expression in glioblastomas promotes cell cohesion, collective invasion of basement membrane in vitro and orthotopic tumor growth in mice
( L7 H% j( Y8 H* Q, h* Ehttp://www.nature.com/onc/journa ... pdf/onc2013305a.pdf! }3 s% ?0 O! t9 `& n
2.β1- and αv-class integrins cooperate to regulate myosin II during rigidity sensing of fibronectin-based microenvironments) F/ I9 q, {/ a( `
http://www.nature.com/ncb/journal/v15/n6/full/ncb2747.html
; M$ D1 i2 s2 r9 @  \: ]; X! b3.Epithelial to Mesenchymal Transition Promotes Breast Cancer Progression via a Fibronectin-dependent STAT3 Signaling Pathway
) I* x1 q/ \& x5 mhttp://www.jbc.org/content/288/25/17954.full.pdf+html
, Z5 R- l- ~$ t4.Mammary epithelial cell interactions with fibronectin stimulate epithelial-mesenchymal transition  ?3 ]0 d2 }$ {4 W
http://www.nature.com/onc/journa ... 1dda993f28dc7dacf9c) O, _; w; f. J, M, ^1 {
5.Integrin αvβ3 and Fibronectin Upregulate Slug in Cancer Cells to Promote Clot Invasion and Metastasis  b3 b+ j! Z1 u0 n3 ^
http://cancerres.aacrjournals.or ... /6175.full.pdf+html* Z5 ~* p7 b( n4 P: d% ?
6.Nuclear factor of activated T cells mediates RhoA-induced fibronectin upregulation in glomerular podocytes2 V+ {, m. {4 G8 h, D
http://ajprenal.physiology.org/c ... .full-text.pdf+html
( @3 v7 {3 X& U7.Overexpression of fibronectin confers cell adhesion‑mediated drug resistance (CAM-DR) against 5-FU in oral squamous cell carcinoma cells5 p. X1 s+ P+ |: _9 Y
http://www.spandidos-publication ... .2265?text=abstract
4 ?* S' t6 p6 f' K. |8 P  `! o+ K: D8 T  ~0 c

Rank: 2

积分
183 
威望
183  
包包
881  
沙发
发表于 2014-3-28 11:52 |只看该作者
是很多
附件: 你需要登录才可以下载或查看附件。没有帐号?注册
已有 1 人评分包包 收起 理由
细胞海洋 + 15 欢迎参与文献互助

总评分: 包包 + 15   查看全部评分

‹ 上一主题|下一主题
你需要登录后才可以回帖 登录 | 注册
验证问答 换一个

Archiver|干细胞之家 ( 吉ICP备2021004615号-3 )

GMT+8, 2025-6-2 20:37

Powered by Discuz! X1.5

© 2001-2010 Comsenz Inc.